Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Phillips Medisize Launches TheraVolt™ Medical Connectors to Support Next-Gen Device Integration, Connectivity and Performance

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EMA Pilot to Fast-Track Breakthrough Medical...

The European Medicines Agency is set to introduce a...

Predictive Maintenance for Biomedical Equipment Reliability

Implementing advanced predictive maintenance strategies within biomedical equipment systems transforms healthcare technology management from a reactive or preventive approach into a proactive, data-driven discipline. This technological evolution leverages real-time monitoring and analytics to anticipate equipment failures before they occur, ensuring uninterrupted clinical operations and enhanced patient safety.

Equipment as a Service: CAPEX to...

Transitioning from traditional capital expenditure models to operational expenditure through equipment as a service enables healthcare providers to access cutting-edge medical technology while preserving liquid capital and enhancing operational flexibility. This financial evolution addresses the rising costs of medical innovation and the need for scalable, high-performance clinical environments.
  • Designed to address increasing demand for advanced medical connectors in growing specialties such as electrophysiology
  • Enhanced cross-platform compatibility helps simplify device integration, increase longevity of capital equipment, reduce customization development time and lower costs
  • The first of several Phillips Medisize–branded medical connectors planned to launch over the next 18–24 months, TheraVolt provides device engineers enhanced functionality, offering solutions to handle both signals and high voltage lines
  • These tailored offerings for medical applications leverage 80+ years of global leadership in interconnect solutions from Molex, combined with Phillips Medisize’s 60+ years of medical experience.On June 9, 2025, Phillips Medisize, a Molex company and a leader in the design, engineering and manufacturing of medtech, pharmaceutical drug delivery and in vitro diagnostic devices, announces the launch of TheraVolt™ Medical Connectors. As the first medical connectors launched under the Phillips Medisize brand, TheraVolt is engineered to optimize device integration, functionality, reliability and performance. TheraVolt provides device engineers enhanced functionality, offering solutions to handle both signals and high voltage lines.Emerging trends in electrophysiology (EP), most notably the rapid adoption of pulsed field ablation (PFA) technology, are driving increased demand for advanced medical connectors that support higher pin count densities and compact design. With enhanced cross-platform compatibility, TheraVolt Medical Connectors help simplify medical device integration, increase longevity of capital equipment, reduce customization development time and lower costs. This can enable more efficient solutions and greater flexibility for medical device companies developing PFA treatment for patients living with atrial fibrillation.

    “With the launch of TheraVolt, the first of several Phillips Medisize–branded connectors, we are excited to bring deeper collaboration and innovation to complement our exceptional contract design and manufacturing services and proven Molex connectivity solutions to our medtech customers,” said Pete Soupir, vice president, MedTech segment at Phillips Medisize. “TheraVolt Medical Connectors empower our medical device customers to develop next-gen EP devices with enhanced integration, connectivity and performance. Their high pin count and high voltage clearance is particularly valuable in medical devices used in electrophysiology treatments, with multiple therapy options, complex functions and expanded data collection.”

    These tailored offerings for medical applications leverage 80+ years of global leadership in interconnect solutions from Molex, combined with more than 60 years of medical experience from Phillips Medisize. TheraVolt Medical Connectors support next-generation medical device integration and performance through:

    • High Pin Count and Voltage Clearance: Enables the integration of more functionalities, allowing medical device engineers to design multi-therapy medical devices with expanded capabilities, advanced functions and increased data collection.
    • Design Flexibility and Customization: Available off-the-shelf with the flexibility to be tailored to meet diverse application demands, with customizable configurations for specific pin counts and precise electrical requirements.
    • Sterilization Compatibility: Engineered to withstand multiple autoclave cycles, maintaining integrity and performance even under repeated exposure to harsh sterilization processes.
    • Safety and Reliability: Designed to support compliance with IEC and IPC requirements, helping to promote dependable operation in medical applications.

    Additional Phillips Medisize Medical Connectors are in development and will be delivered over the next 18–24 months.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

EMA Pilot to Fast-Track Breakthrough Medical Devices in EU

The European Medicines Agency is set to introduce a...

Predictive Maintenance for Biomedical Equipment Reliability

Implementing advanced predictive maintenance strategies within biomedical equipment systems transforms healthcare technology management from a reactive or preventive approach into a proactive, data-driven discipline. This technological evolution leverages real-time monitoring and analytics to anticipate equipment failures before they occur, ensuring uninterrupted clinical operations and enhanced patient safety.

Equipment as a Service: CAPEX to OPEX Shift in Healthcare

Transitioning from traditional capital expenditure models to operational expenditure through equipment as a service enables healthcare providers to access cutting-edge medical technology while preserving liquid capital and enhancing operational flexibility. This financial evolution addresses the rising costs of medical innovation and the need for scalable, high-performance clinical environments.

Healthcare Financing Models Supporting Modern Care Delivery

The transformation of the economic foundations of medicine from a volume-based to a value-based model represents the most significant shift in clinical administration in over a generation. In an era of rising costs and an aging population, the traditional "fee-for-service" approach is being replaced by sophisticated financial structures that incentivize high-quality outcomes and long-term health maintenance. By integrating insurance innovation, sustainable investment strategies, and data-driven cost optimization, healthcare financing models supporting modern care delivery are becoming the primary driver of clinical sustainability and innovation. This evolution ensures that financial resources are allocated where they have the most impact improving the lives of patients and ensuring that the healthcare system remains resilient and accessible for every member of society.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »